To test whether this stability change involved proteasome-mediated degradation, we assessed the ubiquitination of LAMP2 in MG132-treated FAM215A-overexpressing or -knockdown HCC cells. The gene discussed is LAMP2; the disease is hepatocellular carcinoma.